PureTech Health (PRTC) Non-Current Assets (2019 - 2025)
PureTech Health (PRTC) reported Non-Current Assets of $229.7 million for Q4 2025, up 6.15% year-over-year from $216.4 million in Q4 2024, and up 9.98% quarter-over-quarter from $208.9 million in Q2 2025.
PureTech Health (PRTC) Non-Current Assets (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 7 years of Non-Current Assets data on file, last reported at $229.7 million in Q4 2025.
- Non-Current Assets for Q4 2025 came in at $229.7 million, up 6.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $229.7 million (up 6.15% YoY), and the FY2025 annual result was $229.7 million, up 6.15% from the prior year.
- Non-Current Assets grew to $229.7 million in Q4 2025 per PRTC's latest filing, from $208.9 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $444.2 million in Q4 2021 and troughed at $71.1 million in Q2 2024.
- A 5-year average of $261.9 million and a median of $229.7 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets sank 37.6% in 2024, then surged 193.58% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $444.2 million in 2021, then declined by 28.76% to $316.5 million in 2022, then advanced by 9.58% to $346.8 million in 2023, then sank by 37.6% to $216.4 million in 2024, then advanced by 6.15% to $229.7 million in 2025.
- Business Quant data shows PRTC's Non-Current Assets at $229.7 million in Q4 2025, $208.9 million in Q2 2025, and $216.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 229.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 229.69 Mn |
| Jun 30, 2025 | 208.85 Mn |
| Dec 31, 2024 | 216.38 Mn |
| Jun 30, 2024 | 71.14 Mn |
| Dec 31, 2023 | 346.77 Mn |
| Dec 31, 2022 | 316.45 Mn |
| Dec 31, 2021 | 444.20 Mn |
| Dec 31, 2020 | 575.65 Mn |
| Dec 31, 2019 | 772.33 Mn |